Skip to content

Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection

Six Versus Twelve Month SurveillAnce Following Resection of Nonpedunculated ColorectaL Polyps 20-50 mm IN Size Without High Grade Dysplasia (HGD)

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07198945
Acronym
STARLING
Enrollment
546
Registered
2025-09-30
Start date
2026-06-09
Completion date
2030-02-01
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma, Colon Cancer, Colon Polyp, Endoscopic Resection, Recurrence, Local Neoplasm, Serrated Polyp

Keywords

Polyp Resection, Colonoscopy, Recurrence, Surveillance Interval, Patient Experience

Brief summary

The study will compare the use of a 6-month follow-up vs a 12-month follow-up after the removal of a large non-pedunculated polyp 20-50mm in size and without high grade dysplasia.

Interventions

PROCEDURE6-month follow-up

Eligible patients randomized to the 6-month follow-up arm will undergo their first surveillance procedure 6 months after the removal of their large polyp to check for recurrent polyp tissue.

PROCEDURE12-month follow-up

Eligible patients randomized to the 12-month follow-up arm will undergo their first surveillance procedure 12 months after the removal of their large polyp to check for recurrent polyp tissue.

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient Criteria 1. ≥ 18 years of age 2. Ability to provide informed consent 3. Willing and able to complete one electronic survey 4. Presenting for colonoscopy for any indication 5. Ability to understand the requirements of the study and agree to abide by the study restrictions and to return for the required assessments. Polyp Criteria 6. Size 20-50 mm as documented with photo containing open snare of known size as comparison. 7. Histology without high grade dysplasia: 1. Conventional Adenoma: adenoma with or without villous components 2. Serrated: hyperplastic or sessile serrated lesion

Exclusion criteria

Patient Criteria 1. Patients with confirmed diagnosis of inflammatory bowel disease, including Ulcerative Colitis and Crohn's Disease. 2. Patients with a known or suspected diagnosis of any of the following polyposis or non-polyposis syndromes with known genetic mutations: * Familial Adenomatous Polyposis Syndrome * MUTYH associated Polyposis Syndrome * Juvenile Polyposis Syndrome * Cowden's Syndrome * Peutz-Jeghers Syndrome * Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC) or Lynch Syndrome 3. Patients who have high grade dysplasia found in any polyp ≥ 20 mm removed at the index colonoscopy 4. Patients who have any colorectal cancer by histologic diagnosis at index procedure 5. Patients needing a colonoscopy 6 months or sooner for any indication following the index procedure including burden of synchronous disease, inadequate prep to assess for synchronous disease, inadequate prep that precludes resection of index large polyp, or other reason limiting ability to complete full examination of colon at time of resection. 6. ASA ≥ 4 or documented coagulopathy or severe thrombocytopenia (INR ≥ 2 or platelets ≤ 20). 7. Patients who have more than three ≥ 20mm polyps removed during the index colonoscopy 8. Patients with significant acute or chronic medical, neurologic, or illness that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study. Polyp Criteria 9. Polyp located at appendiceal orifice, ileocecal valve, or intradiverticulum 10. Pedunculated or semi-pedunculated polyps (as defined by Paris Classification type Ip or Isp) 11. A polyp that is classified as a traditional serrated adenoma. 12. Polyps with features of invasive cancer 13. Polyps that are not able to be removed with standard endoscopic techniques for any reason 14. Polyps that are incompletely resected endoscopically at index procedure 15. Polyps removed by endoscopic submucosal dissection (ESD) or by full thickness resection device (FTRD)

Design outcomes

Primary

MeasureTime frameDescription
Rate of recurrence1 dayRate of recurrence will be assessed by identification of recurrent polyp tissue at the follow-up procedure.

Secondary

MeasureTime frameDescription
Time of endoscopic management of recurrent polypAt first surveillance colonoscopy, typically 6 months to 12 monthsThe time it takes to treat recurrent polyp at the follow-up procedure
Perceived difficulty of endoscopic treatment of recurrent polypAt first surveillance colonoscopy, typically 6 months to 12 monthsPerceived difficulty of endoscopic treatment of recurrent polyp will be assessed by the endoscopist based at the follow-up procedure on Likert scale 1 - 5 from very difficult to very easy.
Rate of malignancy identified at first surveillance colonoscopyAt first surveillance colonoscopy, typically 6 months to 12 monthsThe rate of malignancy measured at the first follow-up colonoscopy
Size of recurrent polyp at first surveillance colonoscopyAt first surveillance colonoscopy, typically 6 months to 12 monthsThe size of recurrent polyp tissue as measured by maximum size in millimeters
Number of distinct areas of recurrent polypAt first surveillance colonoscopy, typically 6 months to 12 monthsThe number of areas of recurrent polyp tissue identified at the site of the prior large polyp
Rate of high grade dysplasia identified in recurrent polypAfter surveillance colonoscopy, typically 6 months to 12 monthsThe rate of high grade dysplasia identified in recurrent polyp tissue.
Need for advanced resection techniques to treat recurrent polypAt first surveillance colonoscopy, typically 6 months to 12 monthsWhether advanced techniques (such as the use of endoscopic submucosal dissection or full thickness resection device) are needed to treat recurrent polyp tissue
Need for surgical intervention to treat recurrent polypAt first surveillance colonoscopy, typically 6 months to 12 monthsWhether surgical intervention is needed to treat recurrent polyp tissue
Types of recurrences at follow-upAt first surveillance colonoscopy, typically 6 months to 12 monthsDescription of whether recurrence was visible during the follow-up procedure and confirmed by pathology, visible during the follow-up procedure but not confirmed by pathology, or not visible during the follow-up procedure but confirmed by pathology.
Techniques used to treat recurrent polypAt first surveillance colonoscopy, typically 6 months to 12 monthsThe different techniques that were used to treat the recurrent polyp tissue.
Patient Survey ResultsTypically 1 to 14 days after the large polyp removal procedurePatient reported experience, including patient's comfort level with prolonged index surveillance, likelihood for returning for follow-up colonoscopy with extended interval, and other factors. This survey is multiple questions, and the responses will be reported on a 5-point Likert scale with 1 being very uncomfortable, not at all important, etc to 5 being very comfortable, very important, etc.
Adverse events that occur after the follow-up procedure30 days after first surveillance colonoscopyThe number of complications for each randomization arm during and after the follow-up procedure
Distance patient travelled to the endoscopy unitAt first surveillance colonoscopy, typically 6 months to 12 monthsCalculation of the distance the patient travelled to the endoscopy unit as a surrogate for carbon impact
Cost of equipment used at the resection site during the follow-up colonoscopyAt first surveillance colonoscopy, typically 6 months to 12 monthsThe cost of the equipment that was used at the resection site during the surveillance procedure

Countries

Canada, Slovenia, United States

Contacts

PRINCIPAL_INVESTIGATORJohn J Guardiola, MD

Indiana University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026